Medi Mold announces Rs 100+ Cr investment to set up India’s first 3D-printed ortho implant facility

Medi-Mold, a leading manufacturer of medical-grade molds and precision tooling based within the Andhra Pradesh MedTech Zone (AMTZ), has entered into a strategic partnership with OIC International (USA) and AddUp (France) to establish a state-of-the-art 3D printed orthopaedic implant manufacturing facility in Vizag.

The Memorandum of Understanding (MoU) for this strategic collaboration was signed in New Delhi in the presence of Ajay Sood, Principal scientific adviser to the Government of India (PMO Office, New Delhi).

The partnership brings together US-based OIC’s FDA-approved implant technology, French additive manufacturing systems, and India’s largest MedTech ecosystem (AMTZ). A dedicated manufacturing line will be set up within AMTZ to produce 3D-printed orthopaedic implants across trauma, spine, hip, and other segments.

As part of the transaction, Medi-Mold has agreed to an investment outlay of over Rs 100 crore towards OIC International’s setup, India entry, manufacturing, and expansion plans. The capital will be deployed to set up and scale the 3D printed implants facility and localise production, thereby reducing India’s reliance on imports.

It will also support the transfer of proprietary technology, patents, and manufacturing SOPs, and the development of a specialised workforce for advanced MedTech manufacturing.

The facility will leverage AMTZ’s advanced testing labs, machining centres, and regulatory infrastructure to produce high-quality implants at globally competitive costs.

Wodehouse Capital Advisors acted as the exclusive financial and India market entry advisor to OIC for this transaction. Sraboni Haralalka, Executive Director, Wodehouse Capital Advisors said, “This collaboration sets the stage for India to emerge as a global center for advanced orthopaedic implant manufacturing.”